Last reviewed · How we verify
Vosoritide Injection [Voxzogo]
At a glance
| Generic name | Vosoritide Injection [Voxzogo] |
|---|---|
| Also known as | Vosoritide, BMN111 |
| Sponsor | BioMarin Pharmaceutical |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vosoritide Injection [Voxzogo] CI brief — competitive landscape report
- Vosoritide Injection [Voxzogo] updates RSS · CI watch RSS
- BioMarin Pharmaceutical portfolio CI